Checkpoint Inhibitors in Acute Myeloid Leukemia

The prognosis of acute myeloid leukemia (AML) remains unsatisfactory. Among the reasons for the poor response to therapy and high incidence of relapse, there is tumor cell immune escape, as AML blasts can negatively influence various components of the immune system, mostly weakening T-cells. Since l...

Descripción completa

Detalles Bibliográficos
Autores principales: Damiani, Daniela, Tiribelli, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295997/
https://www.ncbi.nlm.nih.gov/pubmed/37371818
http://dx.doi.org/10.3390/biomedicines11061724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295997/
https://www.ncbi.nlm.nih.gov/pubmed/37371818
http://dx.doi.org/10.3390/biomedicines11061724

Ejemplares similares